| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.09 | 0.03 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.41 | 0.04 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.04 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.087 | 0.04 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.13 | 0.04 |